Zura Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	89.82	99.81	1.57	0.73
Cash & Cash Equivalents	89.82	99.81	1.57	0.73
Cash Growth	104.30%	6269.24%	114.89%	-
Other Current Assets	0.66	1.04	0.21	0.42
Total Current Assets	90.47	100.84	1.78	1.15
Property, Plant & Equipment	0.01	0	0	0
Long-Term Investments	0	0	0	139.4
Other Long-Term Assets	0	0	3.49	0
Total Long-Term Assets	0.01	0	3.49	139.4
Total Assets	90.48	100.84	5.26	140.55
Accounts Payable	14.67	20.3	4.43	0.07
Current Debt	0	0	7.76	0
Other Current Liabilities	0	0	2.63	0.2
Total Current Liabilities	14.67	20.3	14.82	0.27
Other Long-Term Liabilities	1.6	0.99	0	10.08
Total Long-Term Liabilities	1.6	0.99	0	10.08
Total Liabilities	16.27	21.29	14.82	10.35
Total Debt	0	0	7.76	0
Retained Earnings	-111.24	-103.49	-32.06	-9.18
Shareholders' Equity	61.01	59.33	-32.06	-9.18
Net Cash / Debt	89.82	99.81	-6.19	0.73
Net Cash / Debt Growth	104.30%	-	-	-
Net Cash Per Share	1.91	3.02	-27.13	0.07
Working Capital	75.8	80.54	-13.04	0.88
Book Value Per Share	1.30	1.79	-140.50	-0.84

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).